Key facts
- · Type: Amendment first sale 2025-10-30 · Amount sold: $500K · SEC filing
- · Type: New offering first sale 2025-10-30 · Amount sold: $450K · Total offering: $450K · SEC filing
- · Type: New offering first sale 2025-01-16 · Amount sold: $404K · Total offering: $404K · SEC filing
- · Type: New offering first sale 2024-02-21 · Amount sold: $1.71M · Total offering: $1.71M · SEC filing
Is Bio Usawa Inc. a real, registered company?
Bio Usawa Inc. is a registered filer with the SEC (CIK 2095500) and has filed since 2025-12-17. 4 filings are on record, the latest on 2026-01-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has Bio Usawa Inc. raised?
Its new offerings report $2.56M sold across 3 offerings, as its own filings state.
Run the free check on Bio Usawa Inc. →
SAN FRANCISCO, CALIFORNIA
2023
Biotechnology
4
$2.56M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-01-27 | Amendment first sale 2025-10-30 | $500K | — | SEC filing |
| 2025-12-17 | New offering first sale 2025-10-30 | $450K | $450K | SEC filing |
| 2025-12-17 | New offering first sale 2025-01-16 | $404K | $404K | SEC filing |
| 2025-12-17 | New offering first sale 2024-02-21 | $1.71M | $1.71M | SEC filing |
Watch Bio Usawa Inc.
Get an email when Bio Usawa Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Bio Usawa Inc.?
Who to contact
- Menghis Bairu — Executive Officer, Director
- Richard Chin — Director
- John Hautman — Executive Officer
- Vincent Ancinetti — Director
- Round: Form D/A (amended) filed 2026-01-27
- Amount sold: $500K
- Industry: Biotechnology
- Founded: 2023
- Based: SAN FRANCISCO, CALIFORNIA
People listed
- Menghis Bairu — Executive Officer, Director
- Richard Chin — Director
- John Hautman — Executive Officer
- Vincent Ancinetti — Director
- Filing: Form D/A (amended) filed 2026-01-27
- Amount sold: $500K
- Industry group: Biotechnology
- Year formed: 2023
- Based: SAN FRANCISCO, CALIFORNIA
- Entity type: Corporation
We'll show it in your MentionFox inbox when Bio Usawa Inc. raises, hires or launches. No email unless you switch it on.
Watch Bio Usawa Inc. →Want the whole picture on Bio Usawa Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Bio Usawa Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bio Usawa Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Bio Usawa Inc.'s own filings with the SEC. The people those filings name are on the team page.